These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17073792)

  • 1. Towards engineered topogenesis of cytochrome b(5) and P450 for in vivo transformation of xenobiotics.
    Kaderbhai MA; Kelly SL; Kaderbhai NN
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1231-5. PubMed ID: 17073792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered in vitro systems for biotransformation studies.
    Doehmer J; Schmalix WA; Greim H
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):513-8. PubMed ID: 7885078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.
    Fasan R; Crook NC; Peters MW; Meinhold P; Buelter T; Landwehr M; Cirino PC; Arnold FH
    Biotechnol Bioeng; 2011 Mar; 108(3):500-10. PubMed ID: 21246504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].
    Guéguen Y; Mouzat K; Ferrari L; Tissandie E; Lobaccaro JM; Batt AM; Paquet F; Voisin P; Aigueperse J; Gourmelon P; Souidi M
    Ann Biol Clin (Paris); 2006; 64(6):535-48. PubMed ID: 17162257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
    Gillam EM
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochromes P450 and drug discovery.
    Lamb DC; Waterman MR; Kelly SL; Guengerich FP
    Curr Opin Biotechnol; 2007 Dec; 18(6):504-12. PubMed ID: 18006294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biotransformation in occupational medicine: the role of hepatic cytochrome P-450 in the mechanism of action and the biological monitoring of occupational toxic compounds].
    Manno M; Saia B
    Med Lav; 1994; 85(1):11-21. PubMed ID: 8035741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity.
    Behrendorff JB; Huang W; Gillam EM
    Biochem J; 2015 Apr; 467(1):1-15. PubMed ID: 25793416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal peptidase I-mediated processing of an engineered mammalian cytochrome b(5) precursor is an exocytoplasmic post-translocational event in Escherichia coli.
    Kaderbhai NN; Harding V; Kaderbhai MA
    Mol Membr Biol; 2008 Aug; 25(5):388-99. PubMed ID: 18651317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cofactor recycling with immobilized heterologous cytochrome P450 105D1 (CYP105D1).
    Taylor M; Lamb DC; Cannell RJ; Dawson MJ; Kelly SL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):708-11. PubMed ID: 11118349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
    Gillam EM
    Arch Biochem Biophys; 2007 Aug; 464(2):176-86. PubMed ID: 17537393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioconversion of deoxypodophyllotoxin into epipodophyllotoxin in E. coli using human cytochrome P450 3A4.
    Vasilev NP; Julsing MK; Koulman A; Clarkson C; Woerdenbag HJ; Ionkova I; Bos R; Jaroszewski JW; Kayser O; Quax WJ
    J Biotechnol; 2006 Nov; 126(3):383-93. PubMed ID: 16753237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.
    Dutheil F; Beaune P; Loriot MA
    Biochimie; 2008 Mar; 90(3):426-36. PubMed ID: 17997991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes P450: a structure-based summary of biotransformations using representative substrates.
    Brown CM; Reisfeld B; Mayeno AN
    Drug Metab Rev; 2008; 40(1):1-100. PubMed ID: 18259985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards the easier use of P450 enzymes.
    Chefson A; Auclair K
    Mol Biosyst; 2006 Oct; 2(10):462-9. PubMed ID: 17216026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative activities of heterologously expressed CYP107B1 and CYP105D1 in whole-cell biotransformation using Streptomyces lividans TK24.
    Ueno M; Yamashita M; Hashimoto M; Hino M; Fujie A
    J Biosci Bioeng; 2005 Nov; 100(5):567-72. PubMed ID: 16384798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a biologically active apo-cytochrome b5 via heterologous expression in Escherichia coli.
    Kotrbová V; Aimová D; Ingr M; Borek-Dohalská L; Martínek V; Stiborová M
    Protein Expr Purif; 2009 Aug; 66(2):203-9. PubMed ID: 19358889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochromes P450 as useful biocatalysts: addressing the limitations.
    O'Reilly E; Köhler V; Flitsch SL; Turner NJ
    Chem Commun (Camb); 2011 Mar; 47(9):2490-501. PubMed ID: 21264369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects.
    McLean KJ; Girvan HM; Munro AW
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):847-63. PubMed ID: 18028029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.